Increased Serum GP88 (Progranulin) Concentrations in Rheumatoid Arthritis
Authors:
- 7 May 2014
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 37 (5) , 1806-1813
Abstract
GP88 (Progranulin; PGRN) is a secreted glycosylated protein with important functions in several processes, including immune response and cancer growth. Recent reports have shown that PGRN is a therapeutic target for rheumatoid arthritis (RA) because of its capability to bind with tumor necrosis factor receptor (TNFR). However, the serum PGRN level in RA patients has not been investigated. We used enzyme-linked immunosorbent assay (ELISA) to quantify the serum levels of PGRN in 417 healthy subjects, 56 patients with RA and 31 patients with osteoarthritis (OA). In RA patients, we also measured the serum TNF-α and sTNFR concentration. Immunohistochemical staining of PGRN was performed using synovectomy tissue of RA patients. The serum PGRN normal range was established as 40.1 ± 8.7 ng/ml. PGRN levels were not influenced by sex or age. A significant increase in serum PGRN levels was observed in RA (50.2 ± 11.1 ng/ml) and OA (45.4 ± 6.6 ng/ml) groups compared to those in age-matched healthy controls (40.4 ± 9.9 ng/ml) (p < 0.05, Tukey). Further, PGRN levels in the synovial fluid of RA patients (68.4 ± 3.4 ng/ml) were found to be significantly higher than those in OA patients (35.9 ± 16.8 ng/ml). Immunohistochemical staining of PGRN revealed that the highest positive signal was detected in macrophages. Circulating PGRN in RA patients was weakly associated with TNF-α and sTNFR 2 concentration. Furthermore, PGRN/TNF-α ratio was correlated the stage of the disease in RA patients. The concentrations of serum PGRN in RA were found to be significantly higher than those in age-matched healthy controls, although it remains to be clarified how blood PGRN is related to the pathogenesis of RA. Our results showed that the serum PGRN may be a useful approach to monitor the disease activity in RA patients.Keywords
This publication has 36 references indexed in Scilit:
- The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitmentJournal of Neuroinflammation, 2013
- Expression level of the growth factor progranulin is related with development of systemic lupus erythematosusDiagnostic Pathology, 2013
- A systematic review and meta‐analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritisArthritis & Rheumatism, 2012
- Prevention of LPS-Induced Acute Lung Injury in Mice by ProgranulinMediators of Inflammation, 2012
- GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cellsBMC Cancer, 2011
- Progranulin: A promising therapeutic target for rheumatoid arthritisFEBS Letters, 2011
- The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in MiceScience, 2011
- Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancersGynecologic Oncology, 2011
- Granulin‐epithelin precursor binds directly to ADAMTS‐7 and ADAMTS‐12 and inhibits their degradation of cartilage oligomeric matrix proteinArthritis & Rheumatism, 2010
- Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulinJournal of Clinical Investigation, 2008